Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) Operating Income (QoQ) (2012 - 2026)

Analysis

Iqvia Holdings (IQV) Operating Income (QoQ) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.56%
Mar 31, 2026 -18.02%
Dec 31, 2025 13.38%
Sep 30, 2025 9.29%
Jun 30, 2025 2.02%
Mar 31, 2025 -20.77%
Dec 31, 2024 13.82%
Sep 30, 2024 5.77%
Jun 30, 2024 2.77%
Mar 31, 2024 1.00%
Dec 31, 2023 4.16%
Sep 30, 2023 -8.21%
Jun 30, 2023 11.25%
Mar 31, 2023 24.27%
Dec 31, 2022 -19.70%
Sep 30, 2022 4.19%
Jun 30, 2022 -8.48%
Mar 31, 2022 6.91%
Dec 31, 2021 53.31%
Sep 30, 2021 5.59%